1
|
King F, Klonoff DC, Kerr D, Hu J, Lyles C, Quinn C, Adi S, Chen K, Hood K, Salber P, de Clercq C, Hu J, Gabbay R. Digital Diabetes Congress 2018. J Diabetes Sci Technol 2018; 12:1231-1238. [PMID: 30376739 PMCID: PMC6232737 DOI: 10.1177/1932296818805632] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Digital health is capturing the attention of the healthcare community. This paradigm whereby healthcare meets the internet uses sensors that communicate wirelessly along with software residing on smartphones to deliver data, information, treatment recommendations, and in some cases control over an effector device. As artificial intelligence becomes more widely used, this approach to creating individualized treatment plans will increase the opportunities for patients, even if they are in remote settings, to communicate with and learn from healthcare professionals. Simple design is needed to promote use of these tools, especially for the purpose of increased adherence to treatment. Widespread adoption by the healthcare industry will require better outcomes data, which will most likely be in the form of safety and effectiveness results from robust randomized controlled trials, as well as evidence of privacy and security. Such data will be needed to convince investors to direct resources into and regulators to clear new digital health tools. Diabetes Technology Society and William Sansum Diabetes Center launched the Digital Diabetes Congress in 2017 because of great interest in determining the potential benefits, metrics of success, and appropriate components of mobile applications for diabetes. The second annual meeting in this series took place on May 22-23, 2018 in San Francisco. This report contains summaries of the meeting's 4 plenary lectures and 10 sessions. This meeting report presents a summary of how 55 panelists, speakers, and moderators, who are leaders in healthcare technology, see the current and future landscape of digital health tools applied to diabetes.
Collapse
Affiliation(s)
- Fraya King
- Diabetes Technology Society, Burlingame,
CA, USA
- Fraya King, Diabetes Technology Society, 845
Malcolm Rd, Ste 5, Burlingame, CA 94010, USA.
| | | | - David Kerr
- Sansum Diabetes Research Institute,
Santa Barbara, CA, USA
| | | | - Courtney Lyles
- University of California, San Francisco,
San Francisco, CA, USA
| | - Charlene Quinn
- University of Maryland School of
Medicine, Baltimore, MD, USA
| | - Saleh Adi
- University of California, San Francisco,
San Francisco, CA, USA
| | - Kong Chen
- National Institutes of Health, Bethesda,
MD, USA
| | - Korey Hood
- Stanford University School of Medicine,
Palo Alto, CA, USA
| | | | | | | | | |
Collapse
|
2
|
Klonoff DC, Kerr D, Wong JC, Pavlovic Y, Koliwad S, Hu J, Salber P, Aguilera A, Long W, Hamilton G, Chen KY, Adi S. Digital Diabetes Congress 2017. J Diabetes Sci Technol 2017; 11:1045-1052. [PMID: 28786320 PMCID: PMC5951004 DOI: 10.1177/1932296817723037] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
The purpose of developing mobile applications for diabetes is generally to: (1) provide enhanced access to timely information for patients, health care professionals, and researchers; (2) facilitate remote monitoring and diagnosis of patients, often based on information delivered by wearable devices; (3) provide decision support to assist patients in selecting treatment; or (4) deliver timely recommendations for treatment to increase adherence to prescribed therapy. There is a perception that mobile applications can provide meaningful clinical benefits, however, there is only sparse convincing evidence to support this belief at the present time. Compounding this problem is the short life span of digital software, such that if a traditional type of randomized controlled trial is conducted on a product, by the time the study has been designed, approved by an IRB, conducted, and analyzed, the product might have significantly changed to a next generation system. Because of great interest in establishing what are the potential benefits, metrics of success, and appropriate components of mobile applications for diabetes, Diabetes Technology Society and William Sansum Diabetes Center launched the Digital Diabetes Congress, March 7-8, 2017, in San Francisco. This report contains summaries of the meeting's 12 sessions. Each summary was written by the session's moderator who helped develop the session prior to the event and keep it on track during the event. This meeting report presents a summary of how 57 panelists, speakers, and moderators, who are leaders in digital health, see the current and future landscape of digital health tools applied to diabetes.
Collapse
Affiliation(s)
- David C. Klonoff
- Mills-Peninsula Medical Center, San Mateo, CA, USA
- David C. Klonoff, MD, FACP, FRCP (Edin), Fellow AIMBE, Mills-Peninsula Medical Center, 100 S San Mateo Dr, Rm 5147, San Mateo, CA 94401, USA.
| | - David Kerr
- William Sansum Diabetes Center, Santa Barbara, CA, USA
| | - Jenise C. Wong
- University of California, San Francisco, San Francisco, CA, USA
| | | | - Suneil Koliwad
- University of California, San Francisco, San Francisco, CA, USA
| | | | | | | | | | | | - Kong Y. Chen
- National Institutes of Health, Bethesda, MD, USA
| | - Saleh Adi
- University of California, San Francisco, San Francisco, CA, USA
| |
Collapse
|